{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:16:52Z","timestamp":1783685812187,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372062"],"award-info":[{"award-number":["82372062"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LY24H180003"],"award-info":[{"award-number":["LY24H180003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ajps.2026.101165","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:51:29Z","timestamp":1779925889000},"page":"101165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mesoporous polydopamine nanoplatform enhances IL-2 immunotherapy for hepatocellular carcinoma via mild photothermal therapy and lactate regulation"],"prefix":"10.1016","volume":"21","author":[{"given":"Fengkai","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlong","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiji","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6026-3676","authenticated-orcid":false,"given":"Jiansong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofeng","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajps.2026.101165_bib0001","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"10360","key":"10.1016\/j.ajps.2026.101165_bib0002","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ajps.2026.101165_bib0003","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ijc.32723","article-title":"International trends in hepatocellular carcinoma incidence, 1978\u20132012","volume":"147","author":"Petrick","year":"2020","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.ajps.2026.101165_bib0004","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"10.1016\/j.ajps.2026.101165_bib0005","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/ph17081057","article-title":"Hypoxia as a target for combination with transarterial chemoembolization in hepatocellular carcinoma","volume":"17","author":"Wang","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.ajps.2026.101165_bib0006","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jhep.2023.02.032","article-title":"TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma","volume":"79","author":"Tan","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajps.2026.101165_bib0007","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajps.2026.101165_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102622","volume":"72","author":"Jin","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"10474","key":"10.1016\/j.ajps.2026.101165_bib0009","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(24)02575-3","article-title":"Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study","volume":"405","author":"Kudo","year":"2025","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ajps.2026.101165_bib0010","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/hep.32447","article-title":"Emerging immunotherapy for HCC: a guide for hepatologists","volume":"75","author":"Foerster","year":"2022","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ajps.2026.101165_bib0011","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ctrv.2011.06.010","article-title":"Role of the microenvironment in hepatocellular carcinoma development and progression","volume":"38","author":"Wu","year":"2012","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"10.1016\/j.ajps.2026.101165_bib0012","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s12072-020-10104-3","article-title":"Current perspectives on the tumor microenvironment in hepatocellular carcinoma","volume":"14","author":"Santhakumar","year":"2020","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.ajps.2026.101165_bib0013","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2015.10.009","article-title":"Immunotherapy and tumor microenvironment","volume":"370","author":"Tang","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ajps.2026.101165_bib0014","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"10.1016\/j.ajps.2026.101165_bib0015","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.4049\/jimmunol.1490019","article-title":"IL-2: the first effective immunotherapy for human cancer","volume":"192","author":"Rosenberg","year":"2014","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.ajps.2026.101165_bib0016","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"issue":"5751","key":"10.1016\/j.ajps.2026.101165_bib0017","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1126\/science.1117893","article-title":"Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors","volume":"310","author":"Wang","year":"2005","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ajps.2026.101165_bib0018","first-page":"2009","article-title":"Pharmacokinetics of recombinant interleukin-2 in humans","volume":"50","author":"Konrad","year":"1990","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ajps.2026.101165_bib0019","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41467-017-02251-3","article-title":"Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ajps.2026.101165_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22980-w","article-title":"A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy","volume":"12","author":"Hsu","year":"2021","journal-title":"Nat Commun"},{"issue":"40","key":"10.1016\/j.ajps.2026.101165_bib0021","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202308362","article-title":"Sonodynamic cytokine nanocomplexes with specific stimulation towards effector T cell for combination cancer immunotherapy","volume":"62","author":"Xu","year":"2023","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.ajps.2026.101165_bib0022","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ade5686","article-title":"IL-2 is inactivated by the acidic pH environment of tumors enabling engineering of a pH-selective mutein","volume":"7","author":"Gaggero","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ajps.2026.101165_bib0023","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ajps.2026.101165_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108500","article-title":"Lactate limits T cell proliferation via the NAD(H) redox state","volume":"33","author":"Quinn","year":"2020","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.ajps.2026.101165_bib0025","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ijc.26410","article-title":"Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK\/c-Jun activation","volume":"131","author":"Mendler","year":"2012","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.ajps.2026.101165_bib0026","first-page":"1423","article-title":"Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe3+ as a novel theranostic agent for T1\/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer","volume":"6","author":"Shu","year":"2021","journal-title":"Bioact Mater"},{"issue":"48","key":"10.1016\/j.ajps.2026.101165_bib0027","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1002\/adma.201402996","article-title":"Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis","volume":"26","author":"Wang","year":"2014","journal-title":"Adv Mater"},{"issue":"48","key":"10.1016\/j.ajps.2026.101165_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303149","article-title":"Bioactivable STING nanoagonists to synergize NIR-II mild photothermal therapy primed robust and long-term anticancer immunity","volume":"35","author":"Ma","year":"2023","journal-title":"Adv Mater"},{"issue":"2","key":"10.1016\/j.ajps.2026.101165_bib0029","article-title":"Local exosome inhibition potentiates mild photothermal immunotherapy against breast cancer","volume":"12","author":"Chen","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"10.1016\/j.ajps.2026.101165_bib0030","first-page":"738","article-title":"Nanomedicine potentiates mild photothermal therapy for tumor ablation","volume":"16","author":"Jiang","year":"2021","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"10.1016\/j.ajps.2026.101165_bib0031","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03473-9","article-title":"Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer","volume":"9","author":"Nam","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2026.101165_bib0032","article-title":"Metal-containing polydopamine nanomaterials: catalysis, energy, and theranostics","volume":"16","author":"Wang","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.ajps.2026.101165_bib0033","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2022.12.052","article-title":"Triple functional mild photothermal improves gene editing of PD-L1 for enhanced antitumor immunity","volume":"354","author":"Lu","year":"2023","journal-title":"J Controlled Release"},{"issue":"11","key":"10.1016\/j.ajps.2026.101165_bib0034","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.celrep.2018.11.043","article-title":"Dual inhibition of the lactate transporters MCT1 and MCT4 is synthetic lethal with metformin due to NAD+ depletion in cancer cells","volume":"25","author":"Benjamin","year":"2018","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.ajps.2026.101165_bib0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J Immunol Methods"},{"issue":"16","key":"10.1016\/j.ajps.2026.101165_bib0036","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41388-020-1216-5","article-title":"The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment","volume":"39","author":"Brown","year":"2020","journal-title":"Oncogene"},{"issue":"7975","key":"10.1016\/j.ajps.2026.101165_bib0037","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41586-023-06409-6","article-title":"Lactate limits CNS autoimmunity by stabilizing HIF-1\u03b1 in dendritic cells","volume":"620","author":"Sanmarco","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ajps.2026.101165_bib0038","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s13046-019-1396-4","article-title":"From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma","volume":"38","author":"Fu","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.ajps.2026.101165_bib0039","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","article-title":"Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma","volume":"18","author":"Llovet","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajps.2026.101165_bib0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1148\/radiol.211028","article-title":"Transarterial embolization modulates the immune response within target and nontarget hepatocellular carcinomas in a rat model","volume":"303","author":"Tischfield","year":"2022","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.ajps.2026.101165_bib0041","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003311","article-title":"Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy","volume":"9","author":"Pinato","year":"2021","journal-title":"J ImmunoTher Cancer"},{"issue":"2","key":"10.1016\/j.ajps.2026.101165_bib0042","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat Immunol"}],"container-title":["Asian Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087626000516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087626000516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:27:14Z","timestamp":1783682834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1818087626000516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1818087626000516"],"URL":"https:\/\/doi.org\/10.1016\/j.ajps.2026.101165","relation":{},"ISSN":["1818-0876"],"issn-type":[{"value":"1818-0876","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesoporous polydopamine nanoplatform enhances IL-2 immunotherapy for hepatocellular carcinoma via mild photothermal therapy and lactate regulation","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajps.2026.101165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Shenyang Pharmaceutical University. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101165"}}